To access this element change to forms mode OFF
Grant Award View - GA276517
Targeting desmoglein-2 to reinvigorate anti-tumour immunity
GA ID:
GA276517
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
27-Oct-2022
Publish Date:
19-Dec-2022
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2026
Value (AUD):
$1,159,847.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Targeting desmoglein-2 to reinvigorate anti-tumour immunity
Purpose:
Pancreatic cancer and melanoma are amongst the deadliest forms of cancer which continue to rise in prevalence. Despite clinical advances, once metastasised, cancer from any organ is universally fatal. The growth and spread of solid tumours requires access to the blood supply as well as control of the immune response. Our work on tumour vasculature, in these most difficult to treat tumours, has identified an adhesion protein on the cancer cells that may help fight this deadly disease.
GO ID:
GO Title:
Ideas Grants 2022
Internal Reference ID:
2022/GNT2021009
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of South Australia
Recipient ABN:
37 191 313 308
Grant Recipient Location
Suburb:
Mawson Lake
Town/City:
Mawson Lake
Postcode:
5095
State/Territory:
SA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW, VIC, SA, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, UNITED STATES